Tirzepatide Cost: Price Per Month With and Without Insurance

As of November 2026, tirzepatide costs about $1,087 a month at Zepbound's list price, $299 to $449 a month for Zepbound vials or KwikPens bought self-pay from LillyDirect, and $499 a month for self-pay Mounjaro. With commercial insurance that covers it, Lilly's savings card can bring the price down to $25. Compounded tirzepatide costs $120 a month at MaxLife, a flat price that stays the same at every dose.

The tirzepatide price you pay depends on whether you buy brand-name or compounded tirzepatide, whether your insurance covers it, and where you buy it. Below, you'll find each route side by side, what insurance changes, what MaxLife includes, the fees to watch for and the best ways to pay less.

Quick Answer: How Much Does Tirzepatide Cost Per Month?

Here are the scenarios most people fall into, with prices as of November 2026:

• Brand-name list price: about $1,087 per 28 days for Zepbound and $1,112 for Mounjaro pens, the original prices shown on TrumpRx (Zepbound, Mounjaro).
• Zepbound self-pay from LillyDirect: $299 for 2.5 mg, $399 for 5 mg and $449 for 7.5 mg to 15 mg per 28 days, for the single-dose vial or the KwikPen, if you refill within 45 days (LillyDirect).
• Mounjaro self-pay from LillyDirect: $499 a month for each strength (LillyDirect). Mounjaro is approved for type 2 diabetes, not weight loss.
• With commercial insurance that covers it: as little as $25 for a 1- to 3-month fill with Lilly's savings card, through December 31, 2026 (Zepbound savings terms).
• With Medicare Part D: $50 a month for the Zepbound KwikPen through the temporary Medicare GLP-1 Bridge, if you meet its rules (CMS).
• Compounded tirzepatide at MaxLife: $120 a month, flat, the same price at every dose, with the provider review, supplies and shipping included.

Tirzepatide has no generic on sale in the US. The FDA's drug database lists only Lilly's two tirzepatide products, Mounjaro and Zepbound (Drugs@FDA via openFDA), so lower prices come from Lilly's own self-pay programs, insurance, or compounded tirzepatide.

Tirzepatide Price Comparison Table

The table puts the main routes side by side. Lilly prices a "month" as a 28-day supply.

Over a year, the gap is large. Thirteen 28-day fills of Zepbound at list price come to about $14,130. On LillyDirect, a first year that follows the label's dose steps (2.5 mg, then 5 mg, then 7.5 mg or more from the third month) costs $299 + $399 + 11 × $449 = $5,637 if every refill is on time. At MaxLife, compounded tirzepatide stays at $120 a month, flat, the same price at every dose.

How Much Is Tirzepatide Without Insurance?

Without insurance, most people pay $299 to $449 a month for Zepbound from LillyDirect, $499 for Mounjaro, or $120 a month, flat, for compounded tirzepatide through a telehealth program such as MaxLife. Full list price is about $1,087.

That leaves three realistic paths. The first is paying the full cash price for brand-name pens at a retail pharmacy. The second is Eli Lilly's lower self-pay prices through LillyDirect. The third is compounded tirzepatide through a telehealth provider, which is usually the lowest-cost route.

All three involve tirzepatide, but they differ in FDA approval, monthly cost and format: the first two are Eli Lilly's FDA-approved products, while compounded tirzepatide is not FDA-approved.

Zepbound and Mounjaro List Prices

The list price, also called the wholesale acquisition cost, is the price Lilly charges wholesalers before discounts (Lilly price information). As of November 2026, TrumpRx, the federal drug-price site, shows an original price of $1,087 for a month of Zepbound at every strength and $1,112.16 for a month of Mounjaro pens (TrumpRx Zepbound, TrumpRx Mounjaro). People without coverage or a savings program may be charged close to this at a retail pharmacy, and a pharmacy's cash price can differ, so ask before you fill.

At list price, moving from the 2.5 mg starting dose to the 15 mg maximum does not change the price of a month's supply of Zepbound. Lilly's self-pay prices work differently, as the next section shows.

Zepbound Vials and KwikPen Through LillyDirect

LillyDirect, Lilly's online pharmacy service, sells Zepbound single-dose vials and the Zepbound KwikPen to self-pay patients with a prescription. As of November 2026, the prices per 28-day supply are (LillyDirect):

• 2.5 mg: $299
• 5 mg: $399
• 7.5 mg, 10 mg, 12.5 mg and 15 mg: $449, if you refill within 45 days of your last delivery

If a refill comes later than 45 days, the regular price applies: $499 for 7.5 mg and $699 for 10 mg to 15 mg (LillyDirect terms). The 2.5 mg dose is a 4-week starting dose and is not approved as a maintenance dose, so plan your budget around the higher prices. Under the Zepbound label, the usual maintenance doses for weight loss are 5 mg, 10 mg or 15 mg once a week.

The format also matters. Vials require you to draw each dose into a syringe. The KwikPen holds four weekly doses and needs a new pen needle for each injection. Needles and syringes are sold separately. The KwikPen is also available for pickup at Walmart Pharmacy with Lilly's self-pay card, for up to 11 fills a year through December 31, 2026. TrumpRx lists the same Zepbound vial prices and sends orders to LillyDirect.

Prices can change, so confirm them at LillyDirect before you buy.

Compounded Tirzepatide Cost

Compounded tirzepatide is prepared by a licensed pharmacy for one patient's prescription and is not FDA-approved, which means the FDA hasn't reviewed it for safety, effectiveness or quality. It is not a generic of Zepbound or Mounjaro, and it is not made by Eli Lilly.

Prices vary widely between online programs. Many quote a low medication price and add a monthly membership, a consultation fee or shipping on top, so compare the full monthly cost.

Two rules shape where compounded tirzepatide comes from in 2026. The FDA ended the tirzepatide shortage on December 19, 2024, and says tirzepatide is not on its shortage list or on the list of bulk ingredients that outsourcing facilities (503B) may use (FDA). In practice, compounded tirzepatide is prepared by state-licensed 503A pharmacies for individual prescriptions. Ask which pharmacy will fill yours and check its license with your state board of pharmacy.

One more tip: compare compounded tirzepatide by its dose in milligrams, not by vial size. In an August 12, 2026 letter to state medical boards, the FDA warned that compounded GLP-1 vials often come in a different concentration than the brand product, so dose volumes are not interchangeable (FDA letter). Follow the instructions from your provider and pharmacy for your exact prescription.

MaxLife works with licensed partner pharmacies, including Dirx Pharmacy, Southend Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Advanced Pharmacy, Perfect Rx Pharmacy, Health Wealth Pharmacy, Quaker Community Pharmacy, VLS Pharmacy and NewLife Rx Pharmacy. Naming the pharmacy is the signal to look for when you compare compounding programs.

How Much Does Tirzepatide Cost With Insurance?

With commercial insurance that covers Zepbound or Mounjaro, Lilly's savings card can bring your cost down to as little as $25 for a 1-, 2- or 3-month fill through December 31, 2026. Without coverage for weight loss, you pay the self-pay prices above.

Coverage depends on whether tirzepatide is on your plan's formulary, which tier it sits on, what it is prescribed for, and whether you have met your deductible. Coverage for weight loss is still uncommon. In KFF's 2026 employer survey, 18% of firms with 200 or more workers covered GLP-1 drugs for weight loss, including 33% of firms with 5,000 or more workers (KFF). Plans cover these drugs far more often for type 2 diabetes. Lilly also says Zepbound coverage has been restored on select CVS Caremark formularies (Lilly).

What You Might Pay by Plan Type

Your exact cost comes from your plan's formulary and your deductible. These are the published rules as of November 2026:

• Commercial plan that covers Zepbound, with the savings card: as little as $25. The card covers up to $100 per month of your copay ($100, $200 or $300 for a 1-, 2- or 3-month fill) and up to $1,300 a year. For Mounjaro the limits are $150 per month and $1,950 a year (Mounjaro savings terms).
• Commercial plan that does not cover Zepbound: Lilly's card can bring the single-dose pen to as low as $499 for a 1-month fill, or you can use the $299 to $449 self-pay vial or KwikPen.
• High-deductible plan before the deductible is met: you usually pay the plan's negotiated price until you reach the deductible, even when the drug is "covered." The savings card may help, within its limits.
• Medicare Part D, weight management: $50 a month for the Zepbound KwikPen through the Medicare GLP-1 Bridge, from July 1, 2026 to December 31, 2027, if you meet the program's BMI and health criteria. Vials and single-dose pens are not included (Medicare).
• Medicare Part D, other approved uses: Part D plans can cover Zepbound for moderate to severe obstructive sleep apnea and Mounjaro for type 2 diabetes. For Mounjaro, Lilly says about 8 in 10 Part D patients pay $0 to $50 for a 28-day supply.
• Medicaid: states must cover diabetes drugs, but coverage for obesity is optional. As of January 2026, 13 state Medicaid programs covered GLP-1 drugs for obesity, and Medicaid enrollees pay little or nothing in copays (KFF).

Lilly's savings cards are not available to people with Medicare, Medicaid, TRICARE or other government coverage. These rules change each plan year, so check your plan's formulary or call the number on your insurance card.

Prior Authorization and Denials

Even when coverage exists on paper, prior authorization is the barrier most people hit. Plans commonly require a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, sleep apnea or type 2 diabetes. These are the same thresholds used to enroll adults in Zepbound's main weight-loss trial. Many also want proof of earlier weight-loss attempts.

If your claim is denied:

1. Get the written denial, which must explain the reason.
2. Ask your prescriber for a letter of medical necessity that answers that reason.
3. File an internal appeal. For most private plans you have 180 days from the denial notice (HealthCare.gov). Medicare drug plans allow 65 days.
4. If the appeal fails, ask for an external review within 4 months. The insurer must accept the independent reviewer's decision (HealthCare.gov).

The process can take weeks. Our guide to weight loss drugs covered by insurance walks through each step and what Medicare, Medicaid and TRICARE cover.

Tirzepatide Cost Per Month at MaxLife

MaxLife offers compounded tirzepatide at $120 a month, flat: all-inclusive and the same price at every dose. Cancel anytime with notice before your next billing period. There is no membership fee and no hidden fee. The price includes a licensed provider's review and follow-up, the medicine if prescribed, supplies and free expedited shipping. No insurance is needed, and HSA and FSA funds may be eligible; confirm with your plan administrator.

The online intake takes about 2 minutes. An independent licensed provider reviews it, usually within 24 hours, and decides whether a prescription is right for you; you can ask for a video visit. If you are prescribed treatment, a licensed partner pharmacy prepares and ships it. MaxLife is a telehealth patient management platform, not a pharmacy, and it is available in all 50 states, with a Spanish-speaking team. MaxLife is LegitScript certified and offers a Lowest Price & Price Match Guarantee.

For comparison, LillyDirect's lowest Zepbound price is $299, for the 2.5 mg starting dose. At MaxLife, higher doses are available when your provider prescribes them, at the same $120 a month. See the details on the compounded tirzepatide page.

Why Is Tirzepatide So Expensive?

Tirzepatide is expensive mainly because it is a newer brand-name drug with no generic competition. Lilly is the only company the FDA has approved to sell it, as Mounjaro and Zepbound, and brand prices usually fall only after generics arrive.

Pharmacy benefit managers also shape what patients pay. They negotiate prices with manufacturers, decide which drugs land on which formulary tier, and set rules such as prior authorization. Many employers also leave weight-loss drugs out of their plans to control costs, which pushes more people to pay cash (KFF).

Cash prices are now far below list. Lilly's self-pay prices of $299 to $449 are well below the list price, and the Medicare GLP-1 Bridge caps the Zepbound KwikPen at $50 a month for eligible Part D members.

Watch Out for Hidden Fees

The advertised monthly price for tirzepatide through a telehealth provider is often not the total you will pay. Many platforms add membership fees, consultation charges, lab work, coaching or shipping on top of the medication. Some quote a low first-month rate that rises at the first refill. Others bill brand-name medication separately, at the manufacturer's price.

Before you sign up with any provider, ask:

• Is the medication included in the monthly price, or billed separately?
• Are supplies such as needles and alcohol wipes included?
• Is shipping included, or added per shipment?
• Is there a separate membership or platform fee?
• Does the price change after the first month or the first billing period?
• How many months must be paid up front?
• Is the "month" 28 days or a calendar month? (Thirteen 28-day fills a year cost more than 12 monthly bills.)

At MaxLife, the medication if prescribed, the provider review and follow-up, supplies and free expedited shipping are included in the flat $120 a month, and there is no membership fee.

The only number worth comparing is the total cost for a month and for a year, with everything included.

To see how these fees add up across real programs, our guide to the best tirzepatide providers online compares 24 options by what they cost for a month and for a first year, memberships included. For the two biggest brand-name programs, see how much tirzepatide costs on Ro and what Hims & Hers weight loss costs.

How to Lower Your Tirzepatide Cost

If standard prices are out of reach, these are the most effective ways to pay less:

• Manufacturer savings card: with commercial insurance that covers Zepbound or Mounjaro, pay as little as $25 for a 1- to 3-month fill, through December 31, 2026. Not available with government coverage.
• LillyDirect self-pay: Zepbound vials or KwikPens from $299 a month without insurance. Refill within 45 days to keep the $449 price at 7.5 mg and above.
• Medicare GLP-1 Bridge: if you have Part D and meet the criteria, the Zepbound KwikPen costs $50 a month through December 31, 2027.
• HSA or FSA funds: prescription medicines are qualified medical expenses under IRS Publication 502, so pre-tax money can lower your real cost.
• The same price at every dose: some programs charge more after the first month or at higher doses; MaxLife's compounded tirzepatide stays $120 a month, flat.
• Compounded tirzepatide through a licensed provider: usually the lowest monthly price, as long as the prescriber is licensed in your state and the pharmacy is named and licensed.

Our page on the cheapest tirzepatide online compares low-cost options in more detail. Whatever route you choose, use providers licensed in your state and pharmacies you can look up. Unlicensed sellers and "research use only" products carry real safety risks that wipe out any savings.

Is Tirzepatide Worth the Cost?

Whether tirzepatide is worth the cost depends on which price you pay and how long you stay on it.

A 2025 modeling study funded by Eli Lilly and published in Obesity assumed a drug cost of $13,826 a year for tirzepatide. It estimated that, over a lifetime, tirzepatide cost $125,053 to $146,331 per quality-adjusted life year gained compared with lifestyle changes alone, which the authors judged cost-effective at a $150,000 threshold. The model counted long-term benefits beyond the scale, such as fewer heart events and fewer new cases of type 2 diabetes. It studied the brand product at a list-based price, not self-pay or compounded prices.

Treatment length matters too. In the SURMOUNT-4 trial, people who switched from Zepbound to placebo after 36 weeks saw their weight rise by 14% on average over the next 52 weeks, while those who stayed on Zepbound lost a further 5.5% (JAMA, 2024). A monthly cost you can keep up for a year or more is worth more than the cheapest first month followed by a gap in treatment. Talk to your provider about how long treatment may last for you.

How Does Semaglutide Cost Compare?

On self-pay and compounded prices, semaglutide is usually a little cheaper than tirzepatide. As of November 2026, NovoCare Pharmacy sells Wegovy pens self-pay for $199 for each of a new patient's first two fills, then $349 a month, and the Wegovy pill for $149 to $299 a month (NovoCare). At MaxLife, compounded semaglutide is $89 a month, flat.

Price should not be the only factor. In the SURMOUNT-5 trial, a head-to-head study funded by Lilly in adults with obesity and without type 2 diabetes, people taking Zepbound lost an average of 20.2% of their body weight over 72 weeks, compared with 13.7% for Wegovy (NEJM, 2025). These results have not been shown for compounded tirzepatide or compounded semaglutide. The choice between the two is a clinical one for you and your provider. For the full breakdown, see our guide to semaglutide cost per month.

Get Transparent Tirzepatide Pricing

At MaxLife, the flat $120 a month covers the medicine if prescribed, a licensed provider's review and follow-up, supplies and free expedited shipping, with no membership fee and no insurance needed. To see your price before you commit, start with compounded tirzepatide at MaxLife.

Conclusion

Tirzepatide costs range from about $1,087 a month at Zepbound's list price to $299 to $449 for Zepbound self-pay vials and KwikPens, $499 for self-pay Mounjaro, $50 through the Medicare GLP-1 Bridge for eligible Part D members, and as little as $25 with commercial coverage and Lilly's savings card. Compounded tirzepatide at MaxLife is $120 a month, flat, the same price at every dose. There is no generic, so savings come from self-pay programs, insurance, or compounded tirzepatide.

Always compare the total monthly and yearly cost, including memberships, supplies and shipping, before you choose a provider or plan.

Frequently Asked Questions

How much does tirzepatide cost per month without insurance?

As of November 2026, Zepbound costs $299 to $449 per 28 days self-pay from LillyDirect, depending on the dose, and Mounjaro costs $499. List price is about $1,087 a month. Compounded tirzepatide at MaxLife is $120 a month, flat, with the provider review, supplies and shipping included.

How much is tirzepatide with insurance?

If your commercial plan covers Zepbound or Mounjaro, Lilly's savings card can lower your cost to as little as $25 for a 1- to 3-month fill through December 31, 2026. Your exact cost depends on your plan's tier and deductible. Eligible Medicare Part D members can get the Zepbound KwikPen for $50 a month through the Medicare GLP-1 Bridge.

Why is compounded tirzepatide cheaper than Zepbound?

Compounded tirzepatide is prepared by a licensed pharmacy for one patient's prescription rather than made and marketed at scale by Eli Lilly. It is not FDA-approved, which means the FDA hasn't reviewed it for safety, effectiveness or quality, and it is not a generic of Zepbound. Its quality depends on the pharmacy that prepares it, so use a provider that names a licensed pharmacy.

Does tirzepatide have a generic?

No. As of November 2026, the FDA's drug database lists only Lilly's Mounjaro and Zepbound as tirzepatide products, and no generic is sold in the US. The FDA warns against GLP-1 products sold online as "for research purposes" or "not for human consumption" (FDA). See is tirzepatide a peptide? for what those research vials are. The lower-cost options are Lilly's self-pay prices and compounded tirzepatide prescribed by a licensed provider.

Is there a tirzepatide pill, and how much does it cost?

No tirzepatide pill is FDA-approved; Zepbound and Mounjaro are weekly injections. Lilly's weight-loss pill, Foundayo, contains a different medicine, orforglipron. As of November 2026, LillyDirect lists Foundayo at $149 to $299 a month depending on the dose, with some lower prices only through December 31, 2026 (LillyDirect).

How much does a vial of tirzepatide cost?

A month (28 days) of Zepbound single-dose vials costs $299 for 2.5 mg, $399 for 5 mg and $449 for 7.5 mg to 15 mg on LillyDirect, if you refill within 45 days. Syringes are extra. Compounded tirzepatide vials are priced by each program, and their concentration can differ from the brand, so compare by your prescribed dose in milligrams.

Can I use my HSA or FSA to pay for tirzepatide?

Usually, yes. IRS Publication 502 counts prescribed medicines as qualified medical expenses, and a weight-loss treatment for a diagnosed condition such as obesity also qualifies. HSA and FSA funds may be eligible for MaxLife plans. Check with your plan administrator and keep your prescription and receipts.

Does the price change when I move to a higher dose?

It depends on the route. At list price, every Zepbound or Mounjaro strength costs the same. On LillyDirect, Zepbound rises from $299 at 2.5 mg to $399 at 5 mg and $449 at 7.5 mg and above. For compounded tirzepatide through MaxLife, it doesn't: $120 a month is the same price at every dose, and higher doses are available when your provider prescribes them.